John P. Butler, CEO and President at Akebia Therapeutics, Inc. (AKBA), bought 50,000 shares at $3.44 ($172K) on 2019-11-20, disclosed to the SEC on 2019-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| AKBA | SELL | 2025-03-04 | $170K | — | Filing → |
| AKBA | SELL | 2025-02-04 | $606K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $147K | — | Filing → |